Form 10-Q · Quarterly report
Stryker Corporation 10-Q, filed Oct 30, 2026
- Filed
- CIK
- 0000310764
- Accession no.
- 0000310764-26-000061
Summary
Stryker Corporation reported third-quarter 2026 net sales of $6.52 billion, up 7.7% from a year earlier, with organic net sales also up 7.7% and adjusted net earnings per diluted share of $3.52, up 10.3%. For the first nine months of 2026, net sales rose 6.6% to $19.13 billion, with adjusted net earnings per diluted share of $9.81, up 7.1%.
Key points
- Q3 2026 net sales were $6.52 billion, up 7.7% from a year earlier, with organic net sales also up 7.7% and adjusted operating income margin up 60 basis points to 26.2%.
- Q3 2026 net earnings were $753 million, or $1.96 per diluted share, down from $859 million, or $2.22 per diluted share, a year earlier; adjusted net earnings per diluted share were $3.52, up 10.3%.
- MedSurg and Neurotechnology net sales increased 9.2% in Q3 2026, while Orthopaedics net sales increased 5.7%.
- For the first nine months of 2026, net sales rose 6.6% to $19.13 billion and net earnings were $2.774 billion, or $7.19 per diluted share; adjusted net earnings per diluted share were $9.81, up 7.1%.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS ABOUT STRYKER Stryker Corporation ("we" or the "Company") is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology, and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.